참고문헌
- Chen CY, Han F, Zhao C, et al (2008). Long-term results of 934 nasopharyngeal carcinoma treated with radiotherapy alone. Chin J Radiat Oncol, 17, 411-5.
- Edge SB, Byrd DR, Compton CC, et al (2009). American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual, 7th edn. Springer, Berlin Heidelberg New York.
- Kong F-f, Ying H, Du C-R, et al (2014). Effectiveness and toxicities of intensity-modulated radiation therapy for patients with t4 nasopharyngeal carcinoma. PLoS ONE, 9, 91362. https://doi.org/10.1371/journal.pone.0091362
- Kuang WL, Zhou Q, Shen LF (2012). Outcomes and prognostic factors of conformal radiotherapy versus intensitymodulated radiotherapy fornasopharyngeal carcinoma. Clin Transl Oncol, 14, 783-90. https://doi.org/10.1007/s12094-012-0864-5
- Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ (2004). The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol, 22, 4604-12. https://doi.org/10.1200/JCO.2004.10.074
- Lee AW, Lau WH, Tung SY, et al (2005). Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong nasopharyngeal cancer study group. J Clin Oncol, 23, 6966-75. https://doi.org/10.1200/JCO.2004.00.7542
- Lee AW, Sze WM, Au JS, et al (2005). Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys, 61, 1107-16. https://doi.org/10.1016/j.ijrobp.2004.07.702
- Lee N, Harris J, Garden AS, et al (2009). Intensity modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol, 27, 3684-90. https://doi.org/10.1200/JCO.2008.19.9109
- Lee N, Xia P, Quivery JM, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22. https://doi.org/10.1016/S0360-3016(02)02724-4
- Leung TW, Tung SY, Sze WK, et al (2005). Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck, 27, 555-65. https://doi.org/10.1002/hed.20189
- Li-Na Zhao, Bin Zhou, Mei Shi, et al (2012). Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China. Oral Oncol, 48, 864-9. https://doi.org/10.1016/j.oraloncology.2012.03.001
- Lin S, Lu JJ, Han L, Chen Q, Pan J (2010). Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer, 10, 39. https://doi.org/10.1186/1471-2407-10-39
- Phua Chee Ee V, Tan BS, Tan AL, et al (2013). Dose planning study of target volume coverage with intensity-modulated radiotherapy for nasopharyngeal carcinoma: Penang General Hospital experience. Asian Pac J Cancer Prev, 14, 2243-8. https://doi.org/10.7314/APJCP.2013.14.4.2243
- Saleh-Ebrahimi et al (2013). Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis. Radiation Oncology, 8, 20. https://doi.org/10.1186/1748-717X-8-20
- Su SF, Han F, Zhao C, et al (2012). Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys, 82, 327-33. https://doi.org/10.1016/j.ijrobp.2010.09.011
- Sun X, Su S, Chen C, et al (2014). Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities. Radiother Oncol, 110, 398-403. https://doi.org/10.1016/j.radonc.2013.10.020
- Wang R, Wu F, Lu H, et al (2013). Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study. J Cancer Res Clin Oncol, 139, 139-45. https://doi.org/10.1007/s00432-012-1313-0
- Wong FC, Ng AW, Lee VH, et al (2010). Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 76, 138-45. https://doi.org/10.1016/j.ijrobp.2009.01.084
- Xiang L, Wang Y, Xu BQ, et al (2013). Preliminary results of a phase I/II study of simultaneous boost irradiation radiotherapy for locally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 14, 7569-76. https://doi.org/10.7314/APJCP.2013.14.12.7569
- Xiao WW, Han F, Lu TX, et al (2009). Chen CY, Huang Y, Zhao C. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 74, 1070-6. https://doi.org/10.1016/j.ijrobp.2008.09.008
- Yi JL, Gao L, Huang XD, et al (2006). Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys, 65, 161-8. https://doi.org/10.1016/j.ijrobp.2005.12.003
피인용 문헌
- Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma vol.38, pp.4, 2017, https://doi.org/10.1038/aps.2016.148
- Association between XRCC1 single-nucleotide polymorphism and acute radiation reaction in patients with nasopharyngeal carcinoma vol.96, pp.44, 2017, https://doi.org/10.1097/MD.0000000000008202